Women's feedback on a chemopreventive trial for cervical dysplasia

Bieniasz, Mary E.; Underwood, Diana; Bailey, Joanne

doi:10.1053/apnr.2003.016022

Cited by 4 publications

(1 citation statement)

References 10 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Motivators to participation include: the ability to help society [11–14]; a positive doctor-patient relationship and communication [12, 4, 14]; and the ability to gain access to new therapies [12]. Barriers to participation have also been identified in the literature, including: inconvenience of trial participation [11, 12, 4, 14, 13]; lack of awareness of trials [4, 14]; mistrust of the research process [12, 4, 13, 14]; concerns regarding issues such as randomization and disease progression [12, 4, 13, 14]; fear [12]; family considerations [4, 14]; and concerns regarding racism/discrimination [12]. …”

Section: Introductionmentioning

confidence: 99%

The Role of Health Literacy on African American and Hispanic/Latino Perspectives on Cancer Clinical Trials

2011

View full text Add to dashboard Cite

Section: Introductionmentioning

confidence: 99%

The Role of Health Literacy on African American and Hispanic/Latino Perspectives on Cancer Clinical Trials

2011

View full text Add to dashboard Cite

Barriers to recruiting underrepresented populations to cancer clinical trials: A systematic review

Ford¹,

Howerton

Lai

et al. 2007

Cancer

911

877

View full text Add to dashboard Cite

they examined reference lists for eligible articles. Titles and abstracts were reviewed to identify relevant studies. Data on barriers to participation were synthesized both qualitatively and based on statistically significant associations with trial enrollment. Of 5257 studies that were cited, 65 studies were eligible for inclusion in the current analysis, including 46 studies on recruitment into cancer therapeutic trials, 15 studies on recruitment into prevention trials, and 4 studies on recruitment into both prevention and treatment trials. Numerous factors were reported as barriers to participation in cancer-related trials. However, only 20 of the studies reported statistically significant associations between hypothesized barriers and enrollment. The available evidence had limitations in quality regarding representativeness, justification of study methods, the reliability and validity of data-collection methods, potential for bias, and data analysis. The results indicate that underrepresented populations face numerous barriers to participation in cancer-related trials. The current systematic review highlighting the literature on recruitment of underrepresented populations to cancer trials and may be used as the evidence base toward developing an agenda for etiologic and intervention research to reduce the disparities in participation in cancer-related trials. Cancer ;112:228-42. 2008

show abstract

Transparency, trust and minimizing burden to increase recruitment and retention in trials: a systematic review

Natale

Saglimbene

Ruospo

et al. 2021

Journal of Clinical Epidemiology

View full text Add to dashboard Cite

Women's feedback on a chemopreventive trial for cervical dysplasia

Cited by 4 publications

References 10 publications

The Role of Health Literacy on African American and Hispanic/Latino Perspectives on Cancer Clinical Trials

The Role of Health Literacy on African American and Hispanic/Latino Perspectives on Cancer Clinical Trials

Barriers to recruiting underrepresented populations to cancer clinical trials: A systematic review

Transparency, trust and minimizing burden to increase recruitment and retention in trials: a systematic review

Contact Info

Product

Resources

About